Alcoholic liver disease (ALD) is a medical condition caused by excessive and prolonged consumption of alcohol. The primary symptom of ALD is liver inflammation and damage, which can lead to cirrhosis, liver cancer, and ultimately, liver failure. ALD is the most common form of chronic liver disease in the United States, and it is estimated that one in four people who consume alcohol are at risk for developing the condition. The liver is responsible for metabolizing alcohol, but when excessive amounts of alcohol are consumed, the liver is unable to break down the alcohol properly, leading to the buildup of toxic waste products in the liver. This causes inflammation and damage to the liver cells, leading to scarring, or cirrhosis. Cirrhosis is the most severe form of ALD and can lead to liver failure. Other symptoms of ALD may include jaundice (yellowing of the skin and whites of the eyes), fatigue, abdominal pain, nausea, and weight loss. ALD is usually diagnosed after a physical exam, blood tests, and imaging tests. Treatment for ALD typically involves reducing alcohol intake and abstaining from alcohol entirely. Medication may also be prescribed to reduce inflammation and scarring in the liver, and lifestyle changes such as a healthy diet and regular exercise are also recommended. If untreated, ALD can be fatal. It is important to reduce alcohol intake or abstain from it completely in order to prevent the progression of ALD and its complications.
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China